Ilze Bāra

1.6k citations
22 papers · 387 · 1 hit paper · h-index 10

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 13
    • Advanced Breast Cancer Therapies 4
    • Lung Cancer Diagnosis and Treatment 4
    • Cancer Immunotherapy and Biomarkers 8
    • Lung Cancer Research Studies 6

Ilze Bāra

21 papers receiving 384 citations

Ilze Bāra's Hit Papers

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer 2023 · 107 citations
1070+1+2Years since publication255075100

Peers

Ilze Bāra
Comparison fields: 5 of 50
  • Oncology 217
  • Pulmonary and Respiratory Medicine 158
  • Cancer Research 25
  • Immunology 29
  • Hepatology 8
Replace Diego Márquez-Medina with:
Diego Márquez-Medina Spain
David Vicente Baz Spain
Christina J. Falcon United States
Landon C. Brown United States
Giulia Grizzi Italy
Alessandro Dal Maso Italy
Yoshiro Nakahara Japan
Max Hardy-Werbin Spain
Cláudia Casanova Italy
Yangki Seok South Korea
Ilze Bāra relative to Diego Márquez-Medina Spain Diego Márquez-Medina's profile →
Citations per field
00.5×
Diego Márquez-Medina · 1×
Citations per year

Countries citing papers authored by Ilze Bāra

Since Specialization
Citations

This map shows the geographic impact of Ilze Bāra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilze Bāra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilze Bāra more than expected).

Fields of papers citing papers by Ilze Bāra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilze Bāra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilze Bāra. The network helps show where Ilze Bāra may publish in the future.

Co-authors

The 25 scholars most cited alongside Ilze Bāra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilze Bāra Line = papers co-authored together Ilze Bāra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer
Hit paper breakdown →
2023107
2 201380
3 202342
4 201433
5 202122
6 202019
7 202118
8 202310
9 20209
10 20209
11 20197
12 20216
13 20236
14 20185
15 20204
16 20243
17 20123
18 20231
19 20241
20
[Intestinal invagination: change in its incidence from 1987 to 2008].
20101

About Ilze Bāra

Ilze Bāra is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pathology and Forensic Medicine and Cancer Research, having authored 22 papers that have together received 387 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (6 papers), Advanced Breast Cancer Therapies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (217 citations), Pulmonary and Respiratory Medicine (158 citations), Cancer Research (25 citations), Immunology (29 citations) and Hepatology (8 citations). Ilze Bāra has collaborated with scholars based in United States, Hong Kong and Switzerland. Frequent co-authors include Federico Cappuzzo, Tony Mok, Barbara Klughammer, Robert M. Jotte, Gene Grant Finley, Howard West, Makoto Nishio, Mark A. Socinski, Wei Yu and Julien Mazières. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact